TD Asset Management »

Lb Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $581k 37k 15.79

More positions owned by TD Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
Enbridge (ENB)
Cibc Cad (CM)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Brookfield Corp Cl A Ltd Vt Sh (BN)
JPMorgan Chase & Co. (JPM)
Agnico (AEM)

View all positions for TD Asset Management

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals